274 related articles for article (PubMed ID: 15667502)
1. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.
Kader HA; Tchernev VT; Satyaraj E; Lejnine S; Kotler G; Kingsmore SF; Patel DD
Am J Gastroenterol; 2005 Feb; 100(2):414-23. PubMed ID: 15667502
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of C1q/TNF-related protein-3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance.
Mohamadinarab M; Ahmadi R; Gholamrezayi A; Rahvar F; Naghdalipour M; Setayesh L; Moradi N; Fadaei R; Chamani E; Tavakoli T; Esteghamati A
IUBMB Life; 2020 Aug; 72(8):1698-1704. PubMed ID: 32311832
[TBL] [Abstract][Full Text] [Related]
3. Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy.
Kiernan MG; Coffey JC; Sahebally SM; Tibbitts P; Lyons EM; O'leary E; Owolabi F; Dunne CP
J Crohns Colitis; 2020 Jan; 14(1):118-129. PubMed ID: 31241755
[TBL] [Abstract][Full Text] [Related]
4. Plasma-induced signatures reveal an extracellular milieu possessing an immunoregulatory bias in treatment-naive paediatric inflammatory bowel disease.
Gurram B; Salzman NH; Kaldunski ML; Jia S; Li BU; Stephens M; Sood MR; Hessner MJ
Clin Exp Immunol; 2016 Apr; 184(1):36-49. PubMed ID: 26660358
[TBL] [Abstract][Full Text] [Related]
5. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
[TBL] [Abstract][Full Text] [Related]
6. Chemokine and cytokine levels in inflammatory bowel disease patients.
Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
[TBL] [Abstract][Full Text] [Related]
7. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
Kucharzik T; Stoll R; Lügering N; Domschke W
Clin Exp Immunol; 1995 Jun; 100(3):452-6. PubMed ID: 7774055
[TBL] [Abstract][Full Text] [Related]
8. Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.
Magro F; Araujo F; Pereira P; Meireles E; Diniz-Ribeiro M; Velosom FT
Dig Dis Sci; 2004 Aug; 49(7-8):1265-74. PubMed ID: 15387356
[TBL] [Abstract][Full Text] [Related]
9. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of VEGF and TGF-β1 during exclusive enteral nutrition in IBD.
Wedrychowicz A; Kowalska-Duplaga K; Jedynak-Wasowicz U; Pieczarkowski S; Sladek M; Tomasik P; Fyderek K
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):150-5. PubMed ID: 21788755
[TBL] [Abstract][Full Text] [Related]
11. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis.
Schmidt C; Giese T; Ludwig B; Mueller-Molaian I; Marth T; Zeuzem S; Meuer SC; Stallmach A
Inflamm Bowel Dis; 2005 Jan; 11(1):16-23. PubMed ID: 15674109
[TBL] [Abstract][Full Text] [Related]
13. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta and hepatocyte growth factor plasma levels in patients with inflammatory bowel disease.
Sturm A; Schulte C; Schatton R; Becker A; Cario E; Goebell H; Dignass AU
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):445-50. PubMed ID: 10783999
[TBL] [Abstract][Full Text] [Related]
15. Serum adipokines in inflammatory bowel disease.
Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profile in children with inflammatory bowel disease.
Toptygina AP; Semikina EL; Bobyleva GV; Miroshkina LV; Petrichuk SV
Biochemistry (Mosc); 2014 Dec; 79(12):1371-5. PubMed ID: 25716731
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
19. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
20. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
